Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith A Kal-van Gestel

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Transplantation Direct|November 15, 2019
Living Donor Kidney Transplantation Should Be Promoted Among "Elderly" PatientsMirjam Laging, Judith A Kal-van Gestel, Willem Weimar, et al.
Transplantation|June 14, 2014
Understanding the influence of ethnicity and socioeconomic factors on graft and patient survival after kidney transplantationMirjam Laging, Judith A Kal-van Gestel, Jacqueline van de Wetering, et al.
Clinical Transplants|July 5, 2012
Eight years of outcomes of the Dutch Living Donor Kidney Exchange ProgramMarry de Klerk, Judith A Kal-van Gestel, Bernadette J J M Haase-Kromwijk, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 7, 2012
The relative importance of donor age in deceased and living donor kidney transplantationMirjam Laging, Judith A Kal-van Gestel, Jacqueline van de Wetering, et al.
Transplantation|October 31, 2015
A High Comorbidity Score Should Not be a Contraindication for Kidney TransplantationMirjam Laging, Judith A Kal-van Gestel, Jacqueline van de Wetering, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 10, 2022
Tacrolimus Monotherapy is Safe in Immunologically Low-Risk Kidney Transplant Recipients: A Randomized-Controlled Pilot StudyAnnelies E de Weerd, Zainab Al Fatly, Marieken Boer-Verschragen, et al.
Transplantation|February 3, 2012
Accumulation of unfavorable clinical and socioeconomic factors precludes living donor kidney transplantationJoke I Roodnat, Mirjam Laging, Emma K Massey, et al.
Transplantation|March 26, 2010
Ethnically diverse populations and their participation in living kidney donation programsJoke I Roodnat, Jacqueline van de Wetering, Willij Zuidema, et al.
Frontiers in Immunology|May 1, 2025
Increasing donor kidney age significantly aggravates the negative effect of pretransplant donor-specific anti-HLA antibodies on kidney graft survivalMichiel G H Betjes, Judith A Kal-van Gestel, Dave Roelen, et al.
Transplantation|November 9, 2013
Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparableMirjam Laging, Judith A Kal-van Gestel, Geert W Haasnoot, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Transplantation Direct|November 15, 2019
Living Donor Kidney Transplantation Should Be Promoted Among "Elderly" PatientsMirjam Laging, Judith A Kal-van Gestel, Willem Weimar, et al.
Transplantation|June 14, 2014
Understanding the influence of ethnicity and socioeconomic factors on graft and patient survival after kidney transplantationMirjam Laging, Judith A Kal-van Gestel, Jacqueline van de Wetering, et al.
Clinical Transplants|July 5, 2012
Eight years of outcomes of the Dutch Living Donor Kidney Exchange ProgramMarry de Klerk, Judith A Kal-van Gestel, Bernadette J J M Haase-Kromwijk, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 7, 2012
The relative importance of donor age in deceased and living donor kidney transplantationMirjam Laging, Judith A Kal-van Gestel, Jacqueline van de Wetering, et al.
Transplantation|October 31, 2015
A High Comorbidity Score Should Not be a Contraindication for Kidney TransplantationMirjam Laging, Judith A Kal-van Gestel, Jacqueline van de Wetering, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 10, 2022
Tacrolimus Monotherapy is Safe in Immunologically Low-Risk Kidney Transplant Recipients: A Randomized-Controlled Pilot StudyAnnelies E de Weerd, Zainab Al Fatly, Marieken Boer-Verschragen, et al.
Transplantation|February 3, 2012
Accumulation of unfavorable clinical and socioeconomic factors precludes living donor kidney transplantationJoke I Roodnat, Mirjam Laging, Emma K Massey, et al.
Transplantation|March 26, 2010
Ethnically diverse populations and their participation in living kidney donation programsJoke I Roodnat, Jacqueline van de Wetering, Willij Zuidema, et al.
Frontiers in Immunology|May 1, 2025
Increasing donor kidney age significantly aggravates the negative effect of pretransplant donor-specific anti-HLA antibodies on kidney graft survivalMichiel G H Betjes, Judith A Kal-van Gestel, Dave Roelen, et al.
Transplantation|November 9, 2013
Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparableMirjam Laging, Judith A Kal-van Gestel, Geert W Haasnoot, et al.
Pageof 2